FGF21 and Alzheimer disease: Chen et al., found that FGF21 reduced the the development of neurodegeneration in the AD model by regulating various inflammatory signalling pathways such as MAPK, hypoxia-inducible factor 1α, and protein phosphatase 2A (Chen et al. 2019).